Holt Matthew S.
Insider CIK 1631836 · BLPH Director, 10% owner · AVTR Director · SGFY Director · RCM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SGFY Signify Health, Inc. | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 0 | SEC↗ |
| SGFY Signify Health, Inc. | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 14,672 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2022-05-12 | 2022-05-16 | 6,693 | — | $0 | 7,908 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2022-04-01 | 2022-04-05 | 1,215 | — | $0 | 1,215 | SEC↗ |
| SGFY Signify Health, Inc. | J Other | 2022-02-16 | 2022-02-18 | 7,916 | — | $0 | 0 | SEC↗ |
| SGFY Signify Health, Inc. | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2016-06-17 | 2016-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2016-04-28 | 2016-04-29 | 18,232 | — | $0 | 18,232 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2015-02-19 | 2015-02-23 | 1,070,166 | $12.00 | $12.84M | 4,859,885 | SEC↗ |
| BLPH Bellerophon Therapeutics, | D To issuer | 2015-02-12 | 2015-02-23 | 460,144 | — | $0 | 3,329,575 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2015-02-12 | 2015-02-23 | 460,144 | — | $0 | 3,789,719 | SEC↗ |